Mcrae Capital Management Inc / VRTX
Mcrae Capital Management Inc’s Vertex Pharmaceuticals Inc Position
Does Mcrae Capital Management Inc own Vertex Pharmaceuticals Inc (VRTX)? Yes — 34.1K shares worth $15M (+3.16% of its 13F portfolio) as of Q1 2026, down from 35.6K shares the prior filed quarter.
Position Value
$15M
Q1 2026
Shares
34.1K
% of Portfolio
+3.16%
Quarters Held
17
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 34.1K | $15M | +3.16% |
| Q4 2025 | 35.6K | $16M | +3.29% |
| Q3 2025 | 33.2K | $13M | +2.58% |
| Q2 2025 | 30.5K | $14M | +2.78% |
| Q1 2025 | 30.3K | $15M | +3.10% |
| Q4 2024 | 31.1K | $13M | +2.45% |
| Q3 2024 | 31.9K | $15M | +2.89% |
| Q2 2024 | 33.5K | $16M | +3.58% |
| Q1 2024 | 33.9K | $14M | +3.11% |
| Q4 2023 | 34.7K | $14M | +3.53% |
| Q3 2023 | 35.3K | $12M | +3.63% |
| Q2 2023 | 35.6K | $13M | +3.56% |
| Q1 2023 | 35.3K | $11M | +3.21% |
| Q4 2022 | 35.8K | $10M | +3.02% |
| Q3 2022 | 36.4K | $11M | +3.20% |
| Q2 2022 | 36.5K | $10M | +2.79% |
| Q1 2022 | 28.5K | $7M | +1.68% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mcrae Capital Management Inc’s full portfolio or all institutional holders of VRTX.